CDC Grand Rounds: Newborn screening and improved outcomes

    Insights

    Newborn screening identifies serious health conditions in infants at birth. Early detection through this public health system significantly reduces infant illness and death.

    Area of Science:

    • Public Health
    • Pediatrics
    • Genetics

    Background:

    • Newborn screening is a vital public health practice implemented in the United States since the 1960s.
    • It targets harmful, potentially fatal conditions not apparent at birth, including genetic, endocrine, and metabolic disorders.
    • Universal screening has evolved into a comprehensive state-based system.

    Purpose of the Study:

    • To highlight the significance of universal newborn screening.
    • To underscore its role in early detection and management of infant disorders.
    • To emphasize the public health impact of timely interventions.

    Main Methods:

    • The study describes the established framework of universal newborn screening.
    • It involves education, screening, diagnostic follow-up, and treatment.
    • System monitoring and evaluation are integral components.

    Main Results:

    • Over 98% of approximately 4 million U.S. newborns are screened annually.
    • Early identification facilitates timely treatment and management.
    • This process leads to significant reductions in infant morbidity and mortality.

    Conclusions:

    • Newborn screening is a cornerstone of modern pediatrics and public health.
    • Early detection through screening offers critical opportunities for intervention.
    • The program effectively minimizes the impact of serious infant health conditions.

    Related Concept Videos

    Development of the Oral Microbiota01:28

    Development of the Oral Microbiota

    The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
    Genetic Screens02:46

    Genetic Screens

    Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
    Forward genetic screens
    Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...